This federal contract award, valued at $7,937.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Otezla 30mg tablets, a medication used to treat various medical conditions.
The contract is a firm fixed-price delivery order with a completion date of December 27, 2024. It is not associated with any set-aside designation, indicating open competition. AmerisourceBergen, a for-profit organization registered in the System for Award Management (SAM.gov), has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/27/25, 9:57 AM